水解酸化/SBR/强化絮凝处理抗生素废水  

Hydrolysis Acidification/MSBR/Enhanced Flocculation Process for Treatment of Antibiotics Pharmaceutical Wastewater

作　　者：潘碌亭[1] 王文蕾[1] 吴锦峰[1] 

机构地区：[1]同济大学污染控制与资源化研究国家重点实验室,上海200092

出　　处：《中国给水排水》2011年第4期78-80,85,共4页China Water & Wastewater

基　　金："十一五"国家科技支撑项目(2006BAJ04A09);中国石油天然气股份公司科学研究与技术开发项目(2008D-4801-1)

摘　　要：制药废水成分复杂,而且含有难生物降解和有抑制作用的抗生素等毒性污染物质,难以处理。采用水解酸化/改良SBR(MSBR)强/化絮凝组合工艺处理抗生素制药废水,结果表明:当进水COD≤500 mg/L、BOD5≤200 mg/L、NH3-N≤60 mg/L、PO34--P≤10 mg/L时,最终出水COD<100 mg/L、BOD5<20 mg/L、NH3-N<10 mg/L、PO34--P<0.8 mg/L,各项指标均达到《污水综合排放标准》(GB 8978—1996)的一级标准。Pharmaceutical wastewater is difficult to be degraded because of the complicated composition and toxic pollutants, such as biorefractory and inhibiting antibiotics. The combined process of hydrolysis acidification, MSBR and enhanced floeculation was used to treat this wastewater. The results show that when the influent COD, BOD5 , NH3 - N and pO4^3- - P are equal to or less than 500 mg/L, 200 mg/L, 60 mg/L and 10 mg/L respectively, their final effluent indexes are less than 100 mg/L, 20 mg/L, 10 mg/L and 0.8 mg/L respectively, meeting the first level criteria specified in the Integrated Wastewater Discharge Standard （GB 8978 -1996）.

关 键 词：制药废水 水解酸化 改良SBR 强化絮凝 

分 类 号：X703[环境科学与工程—环境工程]